Veterinary Medicine Information website

Finadyne Transdermal 50 mg/ml pour-on solution for cattle

Not authorised
  • Flunixin meglumine
Download as PDF

Product identification

Medicine name:
Finadyne Transdermal 50 mg/ml pour-on solution for cattle
Active substance:
  • Flunixin meglumine
Target species:
  • Cattle
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Pour-on solution
Withdrawal period by route of administration:
  • Topical use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Norway
Package description:
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton. Container size: 100 ml
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton. Container size: 250 ml
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton. Container size: 1000 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 13-9539
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0323/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download